Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

capecitabine

  • You have access
    Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therapy
    YAOYI ZHANG, XIAOHUI LI, SHENG LI, ZHIJIAN YANG, ROBERT M. HOFFMAN and CHEN YU
    Anticancer Research January 2025, 45 (1) 399-404; DOI: https://doi.org/10.21873/anticanres.17428
  • You have access
    Neoadjuvant Modified Short-course Radiotherapy for Stage IV Rectal Cancer
    HIROSHI DOI, MASAYUKI FUJIWARA, NAOHITO BEPPU, HIROYUKI YOKOYAMA, SHOGO HARUI, AYAKO SUGIHARA, HIDENORI YANAGI, YOSHIO HISHIKAWA, NAOKI YAMANAKA and NORIHIKO KAMIKONYA
    Anticancer Research November 2022, 42 (11) 5587-5595; DOI: https://doi.org/10.21873/anticanres.16066
  • You have access
    Effectiveness of Hyperthermia as Monotherapy and Adjuvant Therapy Approaches Against an In Vitro Model of Colorectal Carcinoma
    GEORGIOS PETRAKIS, THEODORA MANTSO, MICHAIL I. KOUKOURAKIS, MIHALIS I. PANAYIOTIDIS and SOTIRIS BOTAITIS
    Anticancer Research May 2022, 42 (5) 2363-2374; DOI: https://doi.org/10.21873/anticanres.15715
  • You have access
    Proton Pump Inhibitors Ameliorate Capecitabine-induced Hand-Foot Syndrome in Patients With Breast Cancer: A Retrospective Study
    MIHO TAKEMURA, KENJI IKEMURA, TETSUHIRO YOSHINAMI, YUJI TOYOZUMI, TAKUYA SHINTANI, MIKIKO UEDA, KENZO SHIMAZU and MASAHIRO OKUDA
    Anticancer Research May 2022, 42 (5) 2591-2598; DOI: https://doi.org/10.21873/anticanres.15737
  • Open Access
    Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial
    KEISHO CHIN, DAISUKE TAKAHARI, RYOHEI KAWABATA, HISASHI HOSAKA, SO SAITOU, TAKESHI SHIRAISHI, HIROSHI YABUSAKI, MASAHIRO GOTO, MASATO NAKAMURA, HIROSHI IMAMURA, YOSHIAKI SHINDO, FUMIO NAGASHIMA, WATARU ICHIKAWA, TAKASHI SAOTOME, WATARU YAMAMOTO, NAOKI ISHIZUKA and KENSEI YAMAGUCHI
    Anticancer Research May 2022, 42 (5) 2683-2687; DOI: https://doi.org/10.21873/anticanres.15746
  • Open Access
    Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial
    TAKASHI YOSHIOKA, MASANOBU TAKAHASHI, YASUHIRO SAKAMOTO, AKIRA OKITA, TADAHISA FUKUI, YASUKO MURAKAWA, YOSHIAKI SHINDO, HIROO IMAI, HISATSUGU OHORI, HIDEKAZU SHIROTA, NATSUKO CHIBA, YURIKO (ITO) SASAHARA, TAKASHI NOMURA, NORIMASA FUKUSHIMA, TAKUHIRO YAMAGUCHI, HIDEKI SHIMODAIRA and CHIKASHI ISHIOKA
    Anticancer Research April 2022, 42 (4) 2009-2015; DOI: https://doi.org/10.21873/anticanres.15680
  • You have access
    Comparison of Sinusoidal Obstruction Syndrome in Gastric Cancer Patients Receiving S-1/oxaliplatin Versus Capecitabine/oxaliplatin
    EO JIN KIM, MOONHO KIM, SEYOUNG SEO, MI-JUNG KIM, MIN JU KIM and SOOK RYUN PARK
    Anticancer Research January 2021, 41 (1) 391-402; DOI: https://doi.org/10.21873/anticanres.14788
  • You have access
    Current Status of Therapeutic Drug Monitoring of 5-Fluorouracil Prodrugs
    YASUHIRO HASHIMOTO, YOICHIRO YOSHIDA, TEPPEI YAMADA, NAOYA AISU, GUMPEI YOSHIMATSU, FUMIHIRO YOSHIMURA and SUGURU HASEGAWA
    Anticancer Research August 2020, 40 (8) 4655-4661; DOI: https://doi.org/10.21873/anticanres.14464
  • You have access
    Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
    JEAN-DAVID FUMET, JULIE VINCENT, LEILA BENGRINE, AUDREY HENNEQUIN, LAURA GRANCONATO, REMI PALMIER and FRANÇOIS GHIRINGHELLI
    Anticancer Research July 2020, 40 (7) 4011-4015; DOI: https://doi.org/10.21873/anticanres.14395
  • You have access
    Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling
    JAE JUN SIM, MIN HEE PARK, JEONG-HEUM BAEK, HAEJUN LEE, KEUN-YEONG JEONG and HWAN MOOK KIM
    Anticancer Research August 2018, 38 (8) 4667-4676; DOI: https://doi.org/10.21873/anticanres.12772

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire